BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20881608)

  • 1. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
    Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
    J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
    Alano CC; Kauppinen TM; Valls AV; Swanson RA
    Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
    Szabados E; Literati-Nagy P; Farkas B; Sumegi B
    Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
    Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes.
    Alano CC; Tran A; Tao R; Ying W; Karliner JS; Swanson RA
    J Neurosci Res; 2007 Nov; 85(15):3378-85. PubMed ID: 17853438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.
    Cao S; Sun Y; Wang W; Wang B; Zhang Q; Pan C; Yuan Q; Xu F; Wei S; Chen Y
    J Cell Mol Med; 2019 Oct; 23(10):6897-6906. PubMed ID: 31379115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
    Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
    Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.
    Gerö D; Szoleczky P; Chatzianastasiou A; Papapetropoulos A; Szabo C
    Mol Med; 2014 Jul; 20(1):313-28. PubMed ID: 24842055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Liu M; Li Z; Chen GW; Li ZM; Wang LP; Ye JT; Luo HB; Liu PQ
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):14-22. PubMed ID: 24859603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Poly (ADP-ribose) polymerase inhibition attenuates ischemia/reperfusion induced myocardial injury in rat via reducing myocardial nuclear factor κB activity].
    Song ZF; DU B; Ji XP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):997-1002. PubMed ID: 23363712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.
    Kauppinen TM; Swanson RA
    J Immunol; 2005 Feb; 174(4):2288-96. PubMed ID: 15699164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Jing Lin P
    Shock; 2006 Feb; 25(2):168-75. PubMed ID: 16525356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model.
    Yamazaki K; Tanaka S; Sakata R; Miwa S; Oriyanhan W; Takaba K; Minakata K; Marui A; Ikeda T; Toyokuni S; Komeda M; Ueda K
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):143-7. PubMed ID: 22168830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD
    Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
    Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
    J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P; Szabó C
    Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
    Suh SW; Aoyama K; Chen Y; Garnier P; Matsumori Y; Gum E; Liu J; Swanson RA
    J Neurosci; 2003 Nov; 23(33):10681-90. PubMed ID: 14627653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.